BNTC

Benitec Biopharma Inc. · NASDAQ · Healthcare · USD · 10-K for 2026, filed 2026-09-14

Figures on this page computed 2026-11-08 12:56 UTC

Last close

9.54USD

Market data, 2026-11-06

Except where said otherwise: 10-K for 2026, filed 2026-09-14

  • n/aP/E

    We do not hold this figure for this company, so there is nothing to place.

    Price / Earnings per Share (diluted)

    Source
    computed
    Fiscal year
    2026
    Accession
    0001193125-26-390570
    Reported in
    USD
    • computed
    • 10-K for 2026, filed 2026-09-14

    The filing itself

  • n/aROIC

    We do not hold this figure for this company, so there is nothing to place.

    NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash

    Source
    computed
    Fiscal year
    2026
    Accession
    0001193125-26-390570
    Reported in
    USD
    • 10-K for 2026, filed 2026-09-14
    • 10-K for 2026, filed 2026-09-14
    • 10-K for 2026, filed 2026-09-14
    • 10-K for 2026, filed 2026-09-14
    • 10-K for 2026, filed 2026-09-14
    • 10-K for 2026, filed 2026-09-14

    The filing itself

  • n/aNet margin

    We do not hold this figure for this company, so there is nothing to place.

    Net Income / Revenue x 100

    Source
    computed
    Fiscal year
    2026
    Accession
    0001193125-26-390570
    Reported in
    USD
    • 10-K for 2026, filed 2026-09-14
    • 10-K for 2026, filed 2026-09-14

    The filing itself

  • n/aFCF margin

    We do not hold this figure for this company, so there is nothing to place.

    Free Cash Flow / Revenue x 100

    Source
    computed
    Fiscal year
    2026
    Accession
    0001193125-26-390570
    Reported in
    USD
    • 10-K for 2026, filed 2026-09-14
    • 10-K for 2026, filed 2026-09-14

    The filing itself

  • n/aDebt/equity

    We do not hold this figure for this company, so there is nothing to place.

    Total Debt / Shareholders' Equity

    Source
    computed
    Fiscal year
    2026
    Accession
    0001193125-26-390570
    Reported in
    USD
    • 10-K for 2026, filed 2026-09-14
    • 10-K for 2026, filed 2026-09-14

    The filing itself

  • n/aDividend yield

    We do not hold this figure for this company, so there is nothing to place.

    Source
    computed
    Taken on
    2026-11-07
    Reported in
    USD
    • computed

Then and now

lens 3 of 9
Five filed facts, 2013 against 2026.
Fact20132026Change
Sales504,449n/an/a
Profit-3,867,869-45,546,000-1,078%
Free cash flow-9,300,203-16,623,000-78.7%
Debtn/an/an/a
Shares in issuen/a46,558,162n/a

The same five facts for 2013 and 2026, each read from the year's own filing.

The same five facts for 2013 and 2026, each read from the year's own filing.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2013

  • Sales, 2013504,449
    Source
    computed
    Statement
    income
    Fiscal year
    2013
    Reported in
    AUD
  • Sales, 2026n/a10-K for 2026, filed 2026-09-14

    Not held.

    Source
    filed
    Statement
    income
    Fiscal year
    2026
    Accession
    0001193125-26-390570
    Reported in
    USD

    The filing itself

  • Profit, 2013-3,867,869
    Source
    computed
    Statement
    income
    Fiscal year
    2013
    Reported in
    AUD
  • Profit, 2026-45,546,00010-K for 2026, filed 2026-09-14
    Source
    filed
    Statement
    income
    Fiscal year
    2026
    Accession
    0001193125-26-390570
    Reported in
    USD

    The filing itself

  • Free cash flow, 2013-9,300,203
    Source
    computed
    Statement
    income
    Fiscal year
    2013
    Reported in
    AUD
  • Free cash flow, 2026-16,623,00010-K for 2026, filed 2026-09-14
    Source
    filed
    Statement
    income
    Fiscal year
    2026
    Accession
    0001193125-26-390570
    Reported in
    USD

    The filing itself

  • Debt, 2013n/a

    Not held.

    Source
    computed
    Statement
    income
    Fiscal year
    2013
    Reported in
    AUD
  • Debt, 2026n/a10-K for 2026, filed 2026-09-14

    Not held.

    Source
    filed
    Statement
    income
    Fiscal year
    2026
    Accession
    0001193125-26-390570
    Reported in
    USD

    The filing itself

  • Shares in issue, 2013n/a

    Not held.

    Source
    computed
    Statement
    income
    Fiscal year
    2013
    Reported in
    AUD
  • Shares in issue, 202646,558,16210-K for 2026, filed 2026-09-14
    Source
    filed
    Statement
    income
    Fiscal year
    2026
    Accession
    0001193125-26-390570
    Reported in
    USD

    The filing itself

Filed figures cite the filing they come from; figures marked Market data are quotes as of the date shown. Not a recommendation and not advice.

Past figures are not a forecast. Anything we modelled is labelled as ours. You can lose money on any security.